Literature DB >> 16575679

[Cost-effectiveness in wound care].

D Nord1.   

Abstract

INTRODUCTION: In Germany, treatment costs for pressure ulcer, diabetic foot ulcer and ulcus cruris sum up to Euro 5 billion p. a. (cost of materials only). The question is to be answered how much money could be saved to sick funds, if the treatment is switched from traditional wound care, e. g. hydro-colloids to Vacuum Assisted Closure (V.A.C.).
METHODS: Clinical studies are analysed with regard to complication rates and speed of wound healing V.A.C. vs. traditional. Daily costs and the length of treatment are then correlated and compared.
RESULTS: V.A.C. therapy significantly reduces the time for the wound closing process, hospital admissions and complication rates. Despite higher daily treatment costs (cost of material, only), the V.A.C. therapy turns out to be the superior cost-effective method by far. Assumed V.A.C. therapy substitutes other methods by 50 %, sick funds could have saved Euro 0.7 billion p. a. DISCUSSION: The V.A.C. related saving potential is not available to sick funds because the approval process for home care use is still (Jan 2006) ongoing since 1999. The improvement of the relevant decision making process is strongly required to faster provide better care and savings at the same time.

Entities:  

Mesh:

Year:  2006        PMID: 16575679     DOI: 10.1055/s-2006-921433

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  6 in total

1.  [Surgical management of Pyoderma gangrenosum].

Authors:  I Sick; B Trautner; T Ruzicka
Journal:  Hautarzt       Date:  2012-07       Impact factor: 0.751

2.  Mesh graft infection following abdominal hernia repair: risk factor evaluation and strategies of mesh graft preservation. A retrospective analysis of 476 operations.

Authors:  Stefan Stremitzer; Thomas Bachleitner-Hofmann; Bernhard Gradl; Matthias Gruenbeck; Barbara Bachleitner-Hofmann; Martina Mittlboeck; Michael Bergmann
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

3.  [Ankle osteosynthesis infection: vacuum therapy as the treatment of choice].

Authors:  Y Kollrack; G Möllenhoff
Journal:  Unfallchirurg       Date:  2009-04       Impact factor: 1.000

4.  Definition of efficiency in vacuum therapy--a randomised controlled trial comparing with V.A.C. Therapy.

Authors:  Thomas Wild; Stefan Stremitzer; Annita Budzanowski; Thomas Hoelzenbein; Claudia Ludwig; Gerald Ohrenberger
Journal:  Int Wound J       Date:  2008-12       Impact factor: 3.315

5.  How precise is the evaluation of chronic wounds by health care professionals?

Authors:  Stefan Stremitzer; Thomas Wild; Thomas Hoelzenbein
Journal:  Int Wound J       Date:  2007-06       Impact factor: 3.315

6.  [Economic aspects of surgical wound therapies].

Authors:  R E Horch; D Nord; M Augustin; G Germann; M Leffler; A Dragu
Journal:  Chirurg       Date:  2008-06       Impact factor: 0.920

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.